Isatuximab monotherapy or combination therapy with dexamethasone in older adult patients with relapsed/refractory multiple myeloma: a single institution experience

被引：0
|
作者：
Iino, Masaki [1 ]
Mikawa, Takahiro [1 ]
Kido, Shinji [1 ]
Fujimori, Ken [1 ]
机构：
[1] Yamanashi Prefectural Cent Hosp, Yamanashi, Japan
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-273
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 50 条
  • [1] Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma
    Dimopoulos, Meletios
    Bringhen, Sara
    Anttila, Pekka
    Capra, Marcelo
    Cavo, Michele
    Cole, Craig
    Gasparetto, Cristina
    Hungria, Vania
    Jenner, Matthew
    Vorobyev, Vladimir
    Ruiz, Eduardo Yanez
    Yin, Jian Y.
    Saleem, Rao
    Hellet, Maeva
    Mace, Sandrine
    Paiva, Bruno
    Vij, Ravi
    BLOOD, 2021, 137 (09) : 1154 - 1165
  • [2] An evaluation of isatuximab, pomalidomide and dexamethasone for adult patients with relapsed and refractory multiple myeloma
    Piggin, Anna
    Prince, H. Miles
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (05) : 419 - 427
  • [3] EMA Review of Isatuximab in Combination with Pomalidomide and Dexamethasone for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma
    Delgado, Julio
    Zienowicz, Malgorzata
    van Hennik, Paula Boudewina
    Moreau, Alexandre
    Gisselbrecht, Christian
    Enzmann, Harald
    Pignatti, Francesco
    ONCOLOGIST, 2021, 26 (11): : 983 - 987
  • [4] Results from a Phase II Study of Isatuximab As a Single Agent and in Combination with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
    Dimopoulos, Meletios A.
    Bringhen, Sara
    Anttila, Pekka
    Capra, Marcelo
    Cavo, Michele
    Cole, Craig E.
    Gasparetto, Cristina J.
    Hungria, Vania T. M.
    Jenner, Matthew
    Vorobyev, Vladimir
    Ruiz, Eduardo Yanez
    Yin, Jianyun
    Hamlett, Anthony
    Vij, Ravi
    BLOOD, 2018, 132
  • [5] BENDAMUSTINE, LENALIDOMIDE AND DEXAMETHASONE (BLD) COMBINATION THERAPY IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE
    Ciuffreda, L.
    Diomede, D.
    Miccolis, R. M.
    De Santis, G.
    Buquicchio, C.
    Santeramo, T. M.
    Tarantini, G.
    HAEMATOLOGICA, 2016, 101 : 796 - 797
  • [6] Daratumumab, Pomalidomide, and Dexamethasone (DPd) for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Institution Experience
    Abdallah, Al-Ola
    Dunavin, Neil
    McClune, Brian
    Shune, Leyla
    Dias, Ajoy L.
    Mahmoudjafari, Zahra
    Hochard, Erica
    McGuirk, Joseph P.
    Ganguly, Siddhartha
    BLOOD, 2018, 132
  • [7] Phase 1 study of isatuximab monotherapy in Chinese patients with relapsed/refractory multiple myeloma
    Sun, Mingyuan
    Jing, Hongmei
    Qu, Xiaoyan
    Dong, Fei
    Li, Yi
    Feng, Zhaoyi
    Ziti-Ljajic, Samira
    Semiond, Dorothee
    Li, Lingyu
    Qi, Junyuan
    Qiu, Lugui
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [8] Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
    De Novellis, Danilo
    Derudas, Daniele
    Vincelli, Donatella
    Fontana, Raffaele
    Della Pepa, Roberta
    Palmieri, Salvatore
    Accardi, Fabrizio
    Rotondo, Francesco
    Morelli, Emanuela
    Gigliotta, Emilia
    Roccotelli, Daniela
    Marano, Luana
    Barone, Maria Lucia
    Cetani, Giusy
    Esposito, Daniela
    Lazzaro, Antonio
    Delle Cave, Giuseppe
    Serio, Bianca
    Morini, Denise
    Porrazzo, Marika
    Urciuoli, Eleonora
    Masucci, Chiara
    Fanelli, Fulvia
    Rizzo, Michela
    Arcamone, Manuela
    Trastulli, Fabio
    Rocco, Stefano
    Leone, Aldo
    Bianco, Rosario
    Salvatore, Flavia
    Idato, Aurora
    Sicari, Maria
    Tosi, Patrizia
    Rascato, Maria Gabriella
    Di Perna, Maria
    Falcone, Antonietta Pia
    Morello, Lucia
    Carlisi, Melania
    Svanera, Gino
    Annunziata, Mario
    Frigeri, Ferdinando
    Califano, Catello
    Carella, Angelo Michele
    Marcacci, Gianpaolo
    Pane, Fabrizio
    Risitano, Antonio Maria
    Giudice, Valentina
    Botta, Ciro
    Selleri, Carmine
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (01) : 105 - 114
  • [9] IKEMA: Carfilzomib as the preferred combination with isatuximab in relapsed or refractory multiple myeloma patients?
    Cailly, Laura
    Leleu, Xavier
    Gruchet, Cecile
    HEMATOLOGIE, 2021, 27 (05): : 217 - 218
  • [10] Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience
    Trando, Aaron
    Ghamsari, Farid
    Yeung, Philip
    Costello, Caitlin
    Saunders, Ila
    Jeong, Ah-Reum
    BIOMEDICINES, 2025, 13 (01)
12345